multiple myeloma Proteona Driving Adoption of Immune Profiling Platform for CAR-T, Multiple Myeloma Research Premium The single-cell omics company recently awarded $100,000 in grants funding research on its platform and published on its use for characterizing CAR-T cells. Natera Q1 Revenues Grow 62 Percent The company reported $152.3 million in total revenues for the quarter and said the number of tests it processed rose 48 percent from the prior-year quarter. Genome Sequencing Identifies Myeloma Precursor Disease With High Progression Risk Investigators flagged a set of myeloma-defining genomic events that marked precursor conditions that were prone to morph into multiple myeloma. Multiple Myeloma Therapy Targets, Resistance Pathways Identified With Single-Cell Sequencing The researchers found new molecular pathways of resistance, including hypoxia tolerance, protein folding, and mitochondria respiration. MMRF, Dana Farber Partner on Search for Biomarkers Linked to Smoldering Multiple Myeloma Progression By identifying these biomarkers, the partners hope to better predict which SMM patients will progress to multiple myeloma and ultimately develop new treatments. Jul 24, 2020 MMRF to Integrate New NGS Liquid Biopsy Platform With Myeloma Patient Online Registry Premium Jul 10, 2020 Study Spells Out Immune, Genomic, Epigenomic Interactions in Hematological Malignancies Jun 18, 2020 MMRF Taps GNS Healthcare to Analyze Multiple Myeloma Dataset Apr 28, 2020 Immune Cell Shifts Mark Microenvironments of Precursor Cases Progressing to Multiple Myeloma Feb 26, 2020 Adaptive Biotechnologies Q4 Revenues Rise 41 Percent Feb 4, 2020 SkylineDx Partners With German Hospital to Assess Multiple Myeloma Test Dec 20, 2019 Telo Genomics, Mayo Clinic Collaborate on Multiple Myeloma Clinical Studies Dec 9, 2019 Adaptive Biotechnologies, AbbVie Partner on MRD Testing in Multiple Myeloma Drug Trials Sep 17, 2019 Amgen, Adaptive Biotechnologies Expand Partnership on NGS Blood Cancer Monitoring Aug 14, 2019 Adaptive Biotechnologies Plans New Product Launches, Expanded FDA Label for ClonoSeq Premium Jul 1, 2019 MMRF to Bolster Recently Launched Clinical, Genomic Patient Data Registry With Immune Profiles Premium Apr 24, 2019 Multiple Myeloma Sequences Reveal Prognostic Immunoglobulin Translocation Jan 18, 2019 Medicare Covers Adaptive Biotechnologies' ClonoSeq Assay Oct 11, 2018 Multiple Myeloma Subtypes Linked to Patients' African Ancestry Oct 1, 2018 FDA Authorizes Adaptive Biotechnologies NGS Test for Minimal Residual Disease Sep 13, 2018 GWAS Links Six New Loci to Multiple Myeloma Risk, Uncovers Potential Mechanisms Aug 13, 2018 Mt. Sinai Researchers Use Multi-Omics Approach to Personalize Relapsed Multiple Myeloma Treatment May 29, 2018 Sanofi Partners with Adaptive Biotechnologies for Multiple Myeloma Trials May 16, 2018 Studies Lay Path for Blood-Based Testing in Multiple Myeloma Premium Apr 9, 2018 Multiple Myeloma Study Links More Than Three Dozen Genes to Disease Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.